Publications by authors named "Olaf Sowade"

Claim this Profile
V
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study.
Justus G Garweg, Jana Stefanickova, Carel Hoyng, Thomas Schmelter, Tobias Niesen, Olaf Sowade

Ophthalmol Retina· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN.
Hiroko Terasaki, Kunihiko Shiraki, Masahito Ohji, Carola Metzig, Thomas Schmelter, Olaf Sowade

Retina· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Subgroup Analyses From the VIEW Trials.
Tien Yin Wong, Chui Ming Gemmy Cheung, Timothy Y Y Lai, Shih-Jen Chen, Won Ki Lee, Olaf Sowade

Retina· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of visual outcomes in patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor therapy: post hoc analysis of the VIEW studies.
Paolo Lanzetta, Alan F Cruess, Salomon Y Cohen, Jason S Slakter, Todd Katz, Olaf Sowade

Acta Ophthalmol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies.
John Brazier, Dominic Muston, Henrietta Konwea, G Sarah Power, Victor Barzey, Olaf Sowade

Invest Ophthalmol Vis Sci· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Characteristics of the Fellow Eye in Patients with Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the VIEW Studies.
Sebastian Wolf, Francesco Bandello, Anat Loewenstein, Jason Slakter, Todd Katz, Olaf Sowade

Ophthalmologica· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.
Heinz-Peter Schultheiss, Cornelia Piper, Olaf Sowade, Finn Waagstein, Joachim-Friedrich Kapp

Clin Res Cardiol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study.
Yuichiro Ogura, Hiroko Terasaki, Fumi Gomi, Mitsuko Yuzawa, Tomohiro Iida, Olaf Sowade

Br J Ophthalmol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.
Ursula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, David M Brown, Victor Chong, Olaf Sowade

Ophthalmology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis